Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000630

Drug Information
NameKetoconazole    
SynonymsMLS002222255; 1-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone; ketoconazole; BRD-K29113274-001-03-6; Nizoral, Extina, Xolegel, Kuric, Ketoconazole; CID456201; NCGC00025000-03; Lopac0_000666; NCGC00025000-09; AC-15957; (+/-)-cis-1-Acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine; CHEBI:48336; Prestwick2_000389; BIDD:GT0696; BPBio1_000635; KS-1205; Prestwick0_000389; MolPort-003-848-307; Piperazine, (+/-)-1-acetyl-4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-, rel-; HSDB 7447; (+)-Ketoconazole; UPCMLD-DP138:001; K1003_SIGMA; SMR000058460; cis-1-Acetyl-4-[4-[[2-(2,4-; BRN 4303081; cis-1-Acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine; K 1003; NSC 317629; 79156-75-5; UC280_SIGMA; R 41400; NCGC00025000-02; NSC317629; SAM001246983; Prestwick_744; MLS001146934; NCGC00025000-01; NCGC00025000-06; (+/-)-cis-1-Acetyl-4-(4-[(2-[2,4-dichlorophenyl]-2-[1H-imidazol-1-ylmethyl]-1,3-dioxolan-4-yl)-methoxy]phenyl)piperazine; Ketoconazole [USAN:INN:BAN:JAN]; R41,400; MLS002207053; KTZ; NCGC00025000-05; CIS-1-ACETYL-4-(4-((2-(2,4-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YLMETHYL)-1,3-DIOXOLAN-4-YL)METHOXY)PHENYL)PIPERAZINE; Fungoral; MLS000758224; dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-piperazine; Tocris-1103; CPD000058460; BSPBio_000577; NCGC00025000-07; Prestwick3_000389; R-41400; KZ; KCZ; Ketoconazol; Piperazine, (+)-1-acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-; MLS000069784; EINECS 265-667-4; R 41,400; SPBio_002498; HMS2051A19; S1353_Selleck; 65277-42-1; R41400; AC1L9UG3; Ketoderm; CHEMBL75; (+-)-cis-1-Acetyl-4-(p-((2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazine; KW-1414; Fungarest; HMS1569M19; 1-acetyl-4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine; BIM-0050645.0001; LS-110149; Piperazine, 1-acetyl-4-(4-((2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-, cis-; NCGC00025000-04; HMS2089N05; Prestwick1_000389; C26H28Cl2N4O4; EU-0100666; K0045; NCGC00025000-08; UPCMLD-DP138    
Trade NamePerkhotal; Nizoral    
CompanyJohnson & Johnson    
IndicationFungal infectionsApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntifungal Agents    
CAS NumberCAS 65277-42-1
FormularC26H28Cl2N4O4    
PubChem Compound IDCID 456201.    
PubChem Substance IDSID 602765.    
ChEBI47519;    
SuperDrug ATC IDD01AC08;    
SuperDrug CAS ID065277421;    
TargetCytochrome P450 51Inhibitor[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 075273 To Reference
Ref 2Clinical pharmacokinetics and pharmacodynamics of solifenacin. Clin Pharmacokinet. 2009;48(5):281-302. doi: 10.2165/00003088-200948050-00001. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543